Lynne Byers, executive director of NSF International details the facts about how Brexit, and in particular a 'no-deal' scenario, can impact the pharmaceutical industry. / read more /
With the acquisition of contract development, manufacturing, and testing organization Avista Pharma Solutions, Cambrex will enter the market for early stage small-molecule development and testing services. / read more /
A coalition group from the UK's health sector has called on both the UK and EU to ensure the protection of patients and public health when considering the future relationship of the regions post-Brexit. / read more /
After a review of serious side effects, the agency decided to suspend marketing authorizations for quinolone and fluoroquinolone antibiotics and restrict use of remaining fluoroquinolone antibiotics. / read more /
AstraZeneca is set to divest US rights to Synagis (palivizumab) to Swedish Orphan Biovitrum (Sobi), a biopharmaceutical company focused on rare diseases. / read more /
Elis Biomed has been announced as the winner of the Start-Up of the Year Category for the 2018 Cambridge Independent Science and Technology Awards. / read more /
This article will explore the requirements for media and supplements needed to maintain newer cell lines, such as those based on human cells and fungal cells. / read more /
Integrated Biologics Development
To match the growing demand for biopharmaceutical development and manufacturing, Catalent Biologics has invested extensively in its network to create a comprehensive end-to-end offering for its customers. / Read more/
Capsugel® Vcaps® Enteric
Due to the intrinsic enteric properties of Capsugel® Vcaps® Enteric, no coating step is needed. It means that this capsule is a ready-to-use solution that can help you in obtaining significant cost and time savings during pharmaceutical development or compounding.
/ Read more/
New C2MAP automated pretreatment module
Complete LC/MS solution for cell culture analysis
Celebrating this year the 50th anniversary of its presence in Europe, Shimadzu emphasizes its Excellence in Science approach through the release of the new C2MAP-2000 automated pretreatment module for cell culture media analysis. / Read more/
This ebook covers novel technologies for the formulation, manufacture, purification, and delivery of sterile small- and large-molecule drugs, including single-use systems, facilities and equipment, contamination issues, and process analytics.
